EUVIMEDEUVIMED entdecken
Übersichtsarbeit

The Kallikrein-Kinin System and Cardiovascular Diseases: A Narrative Review

Antonis A Manolis, Theodora A Manolis, Apostolos Vouliotis, Antonis S Manolis iD

Angiology · 02.06.2026

DOI: 10.1177/00033197261456785 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Angiology, online erschienen am 02.06.2026. Verfasst von Antonis A Manolis und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of Medicine, Elpis General Hospital, Athens, Greece. Die Arbeit nennt 75 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

This is a narrative review of the plasma kallikrein-kinin system (KKS) which has an important role in human physiology including the cardiovascular (CV) system. Kallikreins are serine proteases, enzymes that cleave proteins, participating in processes like blood pressure (BP) control, inflammation, and coagulation. Kallistatin is an endogenous kallikrein inhibitor with anti-inflammatory, anti-oxidative, and anti-atherosclerotic properties. Kallikrein controls the activity of several proteolytic cascades in the CV system comprising the intrinsic pathway of coagulation, the KKS, the fibrinolytic system, the renin-angiotensin system (RAS), and the complement pathways. Thus, kallikrein plays a crucial role in the pathogenesis of thrombosis, inflammation, and BP regulation. Plasma kallikrein exerts a cardioprotective role, however, when in high concentration or hyperactive, it perpetuates CV disease. Angiotensin-converting enzyme inhibitors and angiotensin AT1 receptor blockers act on both the RAS and the KKS. Moreover, angiotensin II enhances B1 and B2 bradykinin receptor expression via transcriptional mechanisms. These cross-talks explain why both the RAS and KKS are up-regulated in certain circumstances, whereas in others, both systems go the opposite direction (activated RAS/depressed KKS). As the cross-talks between RAS and KKS play an important role in response to different stimuli, considering these cross-talks may help develop drugs targeting the 2 systems.

Schlagwörter

Stichwörter der Autor:innen

angiotensincardiovascularcerebrovascularcoronary artery diseaseheart failurehypertensionkallikreinkallikrein-kininkallistatinrenin-angiotensinstroke

Autor:innen und Institutionen

  • Department of Medicine, Elpis General Hospital, Athens, Greece.
  • Department of Psychiatry, Aiginiteio University Hospital, Athens, Greece.
  • Department of Cardiology, Euroclinic Hospital, Athens, Greece.
  • First Department of Cardiology, Hippokrateio University Hospital, Athens, Greece.

ORCID-Profile: Antonis S Manolis

Zitieren

APA

Manolis, A. A., Manolis, T. A., Vouliotis, A., & Manolis, A. S. (2026). The Kallikrein-Kinin System and Cardiovascular Diseases: A Narrative Review. Angiology. https://doi.org/10.1177/00033197261456785

Vancouver

Manolis AA, Manolis TA, Vouliotis A, Manolis AS. The Kallikrein-Kinin System and Cardiovascular Diseases: A Narrative Review. Angiology. 2026. doi:10.1177/00033197261456785

BibTeX
@article{Manolis2026,
  author = {Manolis, Antonis A and Manolis, Theodora A and Vouliotis, Apostolos and Manolis, Antonis S},
  title = {The Kallikrein-Kinin System and Cardiovascular Diseases: A Narrative Review},
  journal = {Angiology},
  year = {2026},
  doi = {10.1177/00033197261456785}
}
Kostenlos starten →